• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关巨噬细胞衍生的外泌体let-7a通过靶向骨肉瘤中的C15orf41促进骨肉瘤转移。

Tumor-associated macrophages-derived exo-let-7a promotes osteosarcoma metastasis via targeting C15orf41 in osteosarcoma.

作者信息

Yan Chen-Fei, Xia Jun, Qun Wang-Si, Bing Wei-Yi, Guo Wu-Jian, Yong Huang-Gang, Sheng Shi-Jing, Lei Zhao-Guang

机构信息

Department of Orthopedics, Huashan Hospital, Fudan University, Shanghai, China.

出版信息

Environ Toxicol. 2023 Jun;38(6):1318-1331. doi: 10.1002/tox.23766. Epub 2023 Mar 15.

DOI:10.1002/tox.23766
PMID:36919336
Abstract

BACKGROUND

Osteosarcoma (OS) immune environment is complexed and the immune factors-related to OS progression need to be explored. Tumor-associated macrophages (TAMs) are regarded as immune suppressive and tumor-promoting cells. However, the underlying mechanisms through which TAMs function are still fragmentary. Here, we aim to explore the underlying mechanisms by which TAMs regulate OS progression.

METHODS

TAMs from OS tissues were isolated by flow cytometry. Exosomes derived from TAMs were separated using ultracentrifugation and western blotting. Transmission electron microscopy (TEM), and flow cytometry were constructed to characterize TAMs-derived exosomes. Additionally, the differential MicroRNAs (miRNAs) and genes were detected through RNA sequencing, and further validated using real-time PCR (RT-PCR). OS cell metastasis ability was assessed using transwell invasion and scratch wound healing assays. MiRNAs mimic and lentiviral vectors were utilized to explore the effects on OS progression.

RESULTS

Exosome secreted by TAMs accelerated the OS metastasis. Let-7a level was upregulated in TAMs derived exosomes, which downregulated C15orf41 by targeting 3'-untranslated region (UTR). Furthermore, overexpressing let-7a enhanced invasion and migration by blocking the transcription of C15orf41. In consistent, up-regulating let-7a promoted OS progression and made the prognosis to be worse, which can be reversed by C15orf41 overexpression.

CONCLUSION

This study highlighted the critical role of TAMs-derived exosomes in OS progression and explored the potential value of the let-7a/C15orf41 axis as an indicator or target for OS.

摘要

背景

骨肉瘤(OS)的免疫环境复杂,与OS进展相关的免疫因子有待探索。肿瘤相关巨噬细胞(TAM)被认为是具有免疫抑制和促进肿瘤作用的细胞。然而,TAM发挥功能的潜在机制仍不完整。在此,我们旨在探索TAM调节OS进展的潜在机制。

方法

通过流式细胞术分离OS组织中的TAM。使用超速离心和蛋白质印迹法分离TAM来源的外泌体。构建透射电子显微镜(TEM)和流式细胞术以表征TAM来源的外泌体。此外,通过RNA测序检测差异微小RNA(miRNA)和基因,并使用实时聚合酶链反应(RT-PCR)进一步验证。使用Transwell侵袭和划痕伤口愈合试验评估OS细胞转移能力。利用miRNA模拟物和慢病毒载体探索对OS进展的影响。

结果

TAM分泌的外泌体加速了OS转移。在TAM来源的外泌体中,let-7a水平上调,其通过靶向3'-非翻译区(UTR)下调C15orf41。此外,过表达let-7a通过阻断C15orf41的转录增强侵袭和迁移。一致的是,上调let-7a促进了OS进展并使预后变差,而C15orf41过表达可逆转这种情况。

结论

本研究强调了TAM来源的外泌体在OS进展中的关键作用,并探索了let-7a/C15orf41轴作为OS指标或靶点的潜在价值。

相似文献

1
Tumor-associated macrophages-derived exo-let-7a promotes osteosarcoma metastasis via targeting C15orf41 in osteosarcoma.肿瘤相关巨噬细胞衍生的外泌体let-7a通过靶向骨肉瘤中的C15orf41促进骨肉瘤转移。
Environ Toxicol. 2023 Jun;38(6):1318-1331. doi: 10.1002/tox.23766. Epub 2023 Mar 15.
2
miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.M2 极化肿瘤相关巨噬细胞来源的 exosomes 中的 miRNA-221-3p 通过 SOCS3/JAK2/STAT3 轴加重骨肉瘤的生长和转移。
Aging (Albany NY). 2021 Aug 13;13(15):19760-19775. doi: 10.18632/aging.203388.
3
Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.肿瘤抑制性微小RNA-let-7a通过靶向骨肉瘤细胞中的E2F2抑制细胞增殖。
Int J Oncol. 2015 Apr;46(4):1543-50. doi: 10.3892/ijo.2015.2867. Epub 2015 Feb 3.
4
A single nucleotide polymorphism in the 3'-untranslated region of the KRAS gene disrupts the interaction with let-7a and enhances the metastatic potential of osteosarcoma cells.KRAS基因3'-非翻译区的单核苷酸多态性破坏了与let-7a的相互作用,并增强了骨肉瘤细胞的转移潜能。
Int J Mol Med. 2016 Sep;38(3):919-26. doi: 10.3892/ijmm.2016.2661. Epub 2016 Jul 4.
5
Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.MALAT1基因敲低通过调控miR-34a/细胞周期蛋白D1轴抑制骨肉瘤进展。
Int J Oncol. 2019 Jan;54(1):17-28. doi: 10.3892/ijo.2018.4600. Epub 2018 Oct 19.
6
CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.CBX2 是 miRNA let-7a 的一个功能靶标,在骨肉瘤中作为一种肿瘤促进因子发挥作用。
Cancer Med. 2019 Jul;8(8):3981-3991. doi: 10.1002/cam4.2320. Epub 2019 May 31.
7
Circ_0001174 facilitates osteosarcoma cell proliferation, migration, and invasion by targeting the miR-186-5p/MACC1 axis.环状 RNA 0001174 通过靶向 miR-186-5p/MACC1 轴促进骨肉瘤细胞的增殖、迁移和侵袭。
J Orthop Surg Res. 2022 Mar 12;17(1):159. doi: 10.1186/s13018-022-03059-8.
8
Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B.Let-7a通过靶向Aurora-B抑制骨肉瘤细胞生长和肺转移。
Cancer Manag Res. 2018 Nov 26;10:6305-6315. doi: 10.2147/CMAR.S185090. eCollection 2018.
9
Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.巨噬细胞衍生的 CCL18 通过上调 UCA1 的表达促进骨肉瘤的增殖和迁移。
J Mol Med (Berl). 2019 Jan;97(1):49-61. doi: 10.1007/s00109-018-1711-0. Epub 2018 Nov 13.
10
miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.miR-624-5p 通过靶向 PTPRB 抑制 hippo 信号通路促进骨肉瘤细胞的发生和转移。
J Exp Clin Cancer Res. 2019 Dec 11;38(1):488. doi: 10.1186/s13046-019-1491-6.

引用本文的文献

1
The therapeutic potential of exosomes in bone cancers: osteosarcoma, chondrosarcoma, and Ewing sarcoma.外泌体在骨癌(骨肉瘤、软骨肉瘤和尤文肉瘤)中的治疗潜力。
Invest New Drugs. 2025 Jul 5. doi: 10.1007/s10637-025-01551-6.
2
Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential.癌症中巨噬细胞衍生的外泌体:一把具有治疗潜力的双刃剑。
J Nanobiotechnology. 2025 Apr 26;23(1):319. doi: 10.1186/s12951-025-03321-1.
3
Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma.利用纳米颗粒递送 miRNA 治疗骨肉瘤。
Int J Nanomedicine. 2024 Aug 22;19:8641-8660. doi: 10.2147/IJN.S471900. eCollection 2024.
4
The molecular conversations of sarcomas: exosomal non-coding RNAs in tumor's biology and their translational prospects.肉瘤的分子对话:外泌体非编码 RNA 在肿瘤生物学中的作用及其转化前景。
Mol Cancer. 2024 Aug 22;23(1):172. doi: 10.1186/s12943-024-02083-y.
5
Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies.骨肉瘤治疗的进展:将免疫微环境见解与免疫治疗策略相结合。
Front Cell Dev Biol. 2024 Jun 10;12:1394339. doi: 10.3389/fcell.2024.1394339. eCollection 2024.